Plain-English translation of NCT07015138 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Prostate Cancer research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This is a large study comparing two radiation therapy approaches for men with prostate cancer that has spread to 10 or fewer locations in the body. One group receives radiation to all the cancer spots plus standard hormone therapy, while the other group receives radiation only to the primary prostate tumor plus the same hormone therapy. Researchers want to see if treating all the cancer spots—not just the main tumor—helps patients live longer without their cancer getting worse.
When prostate cancer spreads, doctors usually focus radiation on the main tumor in the prostate. However, some evidence suggests that treating all visible cancer spots might improve outcomes. This trial aims to find out whether the added benefit of comprehensive radiation justifies the extra treatment burden on patients.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to one of two groups. Both groups receive standard hormone therapy along with radiation treatments. One group also receives radiation directed at all visible cancer spots throughout the body, while the other receives radiation only to the main prostate tumor. You will have regular visits to monitor your health, blood tests, and imaging scans over several years to track whether your cancer returns and how well you are doing. Researchers will also ask about your quality of life and any side effects you experience.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
China